Use of certain glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly increased risk for new-onset rheumatoid arthritis (RA), particularly with shorte ...
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...
Share on Pinterest Could drugs like Ozempic lower major complications risk after a heart attack? A study in mice shows promise. Image credit: Steve Christo – Corbis/Corbis via Getty Images Recent ...
Share on Pinterest Can medications or lifestyle habits alone help reduce cardiovascular risk in people with diabetes? Focus Pixel Art/Getty Images In a new observational study, the use of GLP-1s ...
Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...
Please provide your email address to receive an email when new articles are posted on . Orforglipron is a once-daily oral GLP-1 receptor agonist that can be taken without food or water restrictions.
A 2026 informational overview of GLPro's blood sugar support formula, Berberine HCL and GLP-1 research context, bariatric gelatin trick recipe variations, proprietary blend dosage transparency, 60-day ...
Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...
Medications like Ozempic aren’t the only way to activate the GLP-1 hormone that helps control appetite and blood sugar. We probably don’t have to tell you this, but the GLP-1 medication phenomenon has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results